Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  by Li, Lei-Shi & Liu, Zhi-Hong
Kidney International, Vol. 66 (2004), pp. 920–923
Epidemiologic data of renal diseases from a single unit in China:
Analysis based on 13,519 renal biopsies
LEI-SHI LI and ZHI-HONG LIU
Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
Epidemiologic data of renal diseases from a single unit in China:
Analysis based on 13,519 renal biopsies. Renal biopsy speci-
mens of 13,519 cases were collected during the period of Jan-
uary 1979 to December 2002 from the Research Institute of
Nephrology, Nanjing University School of Medicine, Nanjing,
China. Analysis of the data of this group of patients showed that
primary glomerulonephritis (GN) remained the most important
and prevalent renal disease in China. The ratio of primary to
secondary GN was 2.75:1. However, it is declining progressively
in the past two decades with an increment in the incidence
of diabetic nephropathy and nephrosclerosis. IgA nephropa-
thy (IgAN) constituted 45.26% of the primary GN, while non-
IgA mesangial proliferative lesions were 25.62%. Membranous
nephropathy was 9.89% and minimal change disease was 0.93%,
remarkably less.
The most prevalent etiology of secondary GN was systemic
lupus erythrematosus (SLE) (54.3%) followed by Henoch-
Scho¨nlein purpura (20.3%), diabetic nephropathy (6.6%), sys-
temic vasculitides (4.0%), and amyloidosis (2.2%). Based on
the study of biopsy materials obtained from 607 cases mani-
festing chronic renal failure, IgAN was identified as the most
frequent cause (26.69%) of chronic renal failure.
China has a long cultural history, and traditional Chi-
nese medicine has been used extensively in treating
nephritis for many years with some success. However,
nephrology as a branch of medicine has developed only
in the past few decades. The Chinese Society of Nephrol-
ogy was founded in December 1980, since then a rapid
progress has been achieved in modern nephrology in this
large country [1]. Renal biopsy was performed routinely
in China in the last 20 years; however, a nation-wide re-
nal registry has not yet been organized. Therefore, this
is a report of epidemiologic data of renal biopsies from
a single unit (Research Institute of Nephrology, Nanjing
University School of Medicine), which is the biggest re-
nal center of this country. It is located in the southeast
area of China, equipped with 150 in-patient beds and a
dialysis center with 80 dialysis machines. Thousands of
patients are referred to this institute from all over the
country each year.
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Renal biopsy specimens of 13,519 cases were collected
during the period of January 1979 to December 2002.
Among them, 7752 cases (57.3%) were male and 5767
cases (42.6%) were female. Their age averaged 32.7 ±
12.2 (9 to 83) years. All the biopsy specimens obtained
were prepared and examined by the same group of clini-
cians and technicians. Analysis included light microscopy,
immunohistology, and electron microscopy. Final diag-
nosis was made for each patient on the basis of both
clinical and histologic investigations. As many patients
came from various regions all over the country, it might
be taken as an illustration of the epidemiology of renal
disease in China.
As shown in Figure 1, the number of renal biopsies
performed each year during the early 1980s was limited,
less than 100 cases each year. There was an abrupt rise
after 1985, reaching 500 cases each year in 1991, and fur-
ther increased to >1000 cases in each year after 1998.
The expanded pool of renal biopsies from kidney disease
patients in the recent years makes the epidemiologic in-
vestigation more reliable.
DISTRIBUTION OF RENAL DISEASES IN CHINA
Table 1 shows the incidence of renal diseases in 13,519
renal biopsies. Primary glomerulonephritis (GN) re-
mained the most important and prevalent kidney disease
in China. The ratio of primary to secondary GN as a whole
was 2.75:1 (9278/3380). However, this ratio is progres-
sively decreasing in the past two decades [2, 3]. As shown
in Figure 2, it started from 3.61:1 (78.3% to 21.7%) in
1979 to 1985 and dropped steadily to 2.01:1 (66.8% to
33.2%) in 1998 and 1999. There was an increase in the
incidence of secondary glomerular diseases such as dia-
betic nephropathy and nephrosclerosis. In addition, this
change might be due to more cases of secondary GN diag-
nosed owing to improvement in the recognition of these
diseases and more sophisticated diagnostic skills.
PREVALANCE OF PRIMARY
GLOMERULAR DISEASES
The pattern of primary glomerular diseases occur-
ring in China is unique in its high prevalence of IgA
920
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Year Fig. 1. Cases of renal biopsies performedeach year.
Table 1. Classification of renal diseases based on 13,519 renal
biopsies
No. of cases %
Primary glomerular diseases 9278 68.64
Secondary glomerular diseases 3359 24.84
Systemic diseases 2673 19.77
Metabolic diseases 345 2.55
Vascular diseases 244 1.80
Infections 97 0.72
Hereditary and congenital renal diseases 131 0.97
Tubulointerstitial diseases 464 3.43
Rare renal disease 37 0.27
Sclerosing glomerulonephritis 132 0.98
Unclassified 118 0.87
Total 13,519 100.00
nephropathy (IgAN) and non-IgA mesangial prolifera-
tive lesion. Among 9278 cases of primary glomerular dis-
eases examined, the most frequent histopathologic lesion
was IgAN (45.26%) and the second one was non-IgA
diffuse mesangial proliferative lesion (25.62%) Both of
these lesions are defined by the mesangial distribution
of Ig(s) as the sole or predominant immune deposits in-
volved. They comprised 70.88% of primary glomerular
diseases in China (Table 2). Whether their high preva-
lence is related to genetic background, environmental
factors, or frequent infections (either bacterial or viral) is
uncertain. While the membranous and minimal change
disease, commonly recorded in the western literature
as the important types of primary glomerular diseases
causing nephrotic syndrome, were remarkably less. Idio-
pathic membranous nephropathy accounted for 9.89%,
while minimal change disease constituted only 0.93%.
The remaining primary glomerular diseases such as focal
segmental glomerulosclerosis (FSGS), IgM nephropathy,
mesangiocapillary GN, and other types of lesions con-
tributed to only a minor part as shown in Table 2 [4, 5].
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Fig. 2. The changing frequency of primary and secondary glomeru-
lonephritis from 1979 to 1999. ∗P < 0.01; ∗∗P < 0.001, compared with
1985.
PREVALANCE OF SECONDARY
GLOMERULAR DISEASES
The most prevalent secondary glomerular dis-
eases among this group of patients is systemic lu-
pus erythematosus (SLE) (54.3%) and followed by
Henoch-Scho¨nlein purpura (20.3%), diabetic nephropa-
thy (6.6%), systemic vasculitides (4.0%), amyloidosis
(2.2%), and hypertension (1.8%). They comprised 89.4%
of the total group of secondary glomerular diseases. The
pattern of secondary glomerular diseases seen in China
is clearly quite different from that of the western coun-
tries. Lupus nephritis is the most common and impor-
tant renal disease in China. While diabetic nephropathy,
the most common renal disease occurring in the United
States, currently represents less than 7% of this group
of patients. No doubt, this tendency might change in the
next few decades, as the incidence of diabetes mellitus
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Table 2. Prevalance of primary glomerular diseases
No. of cases %
IgAN 4199 45.26
MsPGN 2377 25.62
MN 918 9.89
FSGS 557 6.00
IgMN 396 4.27
MPGN 314 3.38
EnPGN 255 2.75
CreGN 176 1.90
MCD 86 0.93
Total 9278 100.00
Abbreviations are: IgAN, IgA nephropathy; MsPGN, mesangial proliferative
glomerulonephritis; MN, membranous nephropathy; FSGS, focal segmental
glomerulosclerosis; IgMN, IgM nephropathy; MPGN, mesangiocapillary
glomerulonephrits; EnPGN, endocapillary proliferative glomerulonephrits;
CreGN, crescentic glomerulonephritis.
Table 3. Glomerulonephritis in systemic diseases
No. of Cases %
Systemic lupus erythematosus 1824 68.23
Henoch-Scho¨nlein purpura 685 25.63
Anti-glomerular basement membrane disease 29 1.08
Rheumatoid arthritis 21 0.79
Sjo¨gren’s syndrome 19 0.71
Mixed connective tissue disease 9 0.34
Nephropathy in pregnancy 23 0.86
Neoplasm 11 0.41
Liver diseases 25 0.94
Multiple myeloma 27 1.01
Total 2673 100.00
Table 4. Glomerular lesions in metabolic diseases
No. of Cases %
Diabetic nephropathy 222 64.35
Amyloidosis 76 22.03
Monoclonal immunoglobulin deposit 35 10.14
disease (MIDD)
Mixed cryoglobulinemia 9 2.61
Dense deposit disease 3 0.87
Total 345 100.00
is progressively increasing in China. The incidence of
secondary glomerular diseases included in this series of
patients are shown in Tables 3 to 6. Interestingly, hepati-
tis B virus infection, a highly prevalent disease in China,
was considered to be the cause of glomerular diseases in
only 34 cases, less than 1% of the total number of pa-
tients. Metabolic disorders (including diabetes) causing
glomerular disease occupied only 2.71% of the total fre-
quency.
HEREDITARY AND RARE DISEASES
In general, many cases of this category such as lipopro-
tein glomerulopathy, obesity-related glomerulopathy,
and Fabry’s disease were identified only in the past
decade. Obviously, some of them might have been missed
Table 5. Glomerular lesions in vascular diseases
No. of cases %
Systemic vasculitis 137 56.15
Benign/malignant nephrosclerosis 62 25.41
HUS/TTP 40 16.39
Systemic sclerosis 5 2.05
Total 244 100.00
HUS/TTP is hemolytic-uremic syndrome/thrombotic thrombocytopenic
purpura.
Table 6. Glomerular diseases associated with infections
No. of cases %
Epidemic heamorrhagic fever 59 60.83
Hepatits B virus infections 34 35.05
Infective endocarditis 4 4.12
Total 97 100.00
Table 7. Hereditary and rare diseases
No. of cases %
Hereditary
Alport syndrome 103 78.63
Thin basement membrane disease 25 19.08
Oligomeganephronia 1 0.76
Medullary cystic disease 2 1.53
Total 131 100.00
Rare diseases
Obesity-related glomerulonepathy 21 56.70
Lipoprotein glomerulopathy 6 16.20
Fibrillary glomerulopathy 4 10.90
Immunotactoid glomerulopathy 2 5.40
Niemann Pick disease 1 2.70
Fabry’s disease 1 2.70
POEMS sydrome 2 5.40
Total 37 100.00
before. Most cases of the Alport syndrome were diag-
nosed in the past 5 years after the introduction of type IV
collagen a chains staining. Therefore, the real frequency
of these diseases should be higher than that shown in
Table 7 and need to be further evaluated.
TUBULOINTERSTITIAL DISEASES
Interstitial nephritides are not uncommon in China,
some are due to drug toxicity, some are allergic or in-
fectious in origin. Aristolochia acid–induced nephropa-
thy was reported repeatedly in the recent 6 years. It
was mainly due to the medical use of a Chinese herb,
Aristolochia manshusieusis, which was conceived as a di-
uretic. Notably, reflux nephropathy is rather rare in China
(Table 8).
HISTOPATHOLOGY OF CHRONIC
RENAL FAILURE
Six hundred and seven cases had their serum creatinine
persistently higher than 3.0 mg/dL diagnosed as chronic
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Table 8. Tubular-interstitial diseases
No. of cases %
Acute interstitial nephritis 159 34.26
Acute tubular necrosis 163 35.13
Chronic interstitial nephritis 101 21.77
Arsitolochic acid nephropathy 27 5.80
Reflux nephropathy 10 2.16
Bartter’s syndrome 4 0.86
Total 464 100.00
Table 9. Histology of chronic renal failure (N = 607)
No. of cases %
Primary glomerular diseases 252 41.50
IgAN 162 26.70
FSGS 58 9.60
MPGN 27 4.40
MN 5 0.82
Secondary glomerular diseases 218 35.91
Renal vasculitis 87 14.33
HSPN 3 0.49
LN 66 10.88
DN 19 3.13
Multiple myeloma 8 1.32
Amyloidosis 8 1.32
Monoclonal immunoglobulin deposit disease 8 1.32
Benign/malignant nephrosclerosis 11 1.81
Toxemia in pregnancy 3 0.49
Hereditary renal disease 5 0.82
Chronic interstitial nephritis 71 11.70
Unclassified 66 10.87
Total 607 100.00
Abbreviations are: IgAN, IgA nephropathy; FSGS, focal segmental glomeru-
losclerosis; MPGN, mesangiocapillary glomerulonephrits; MN, membranous
nephropathy; HSPN, Henoch-Scho¨nlein purpura; LN, lupus nephritis; DN,
diabetic nephropathy.
renal failure of undetermined origin. They were biopsied
with cautions. The results are shown in Table 9. Again
IgAN was identified to be the most frequent cause of
chronic renal failure, amounting to 26.69%. FSGS was an-
other important disease among primary glomerular dis-
eases in causing chronic renal failure, with a frequency
of 9.56%. Among the secondary GNs, renal vasculitis
ranked first (14.4%) with lupus nephritis as second com-
mon cause (10.88%) as shown in Table 9.
CONCLUSION
Primary glomerular disease is still the most common
renal disease in China. IgAN represents more than 40%
of the primary glomerular diseases and is the most impor-
tant cause of end-stage renal failure. Diabetic nephropa-
thy and nephrosclerosis are less common but are
increasing progressively. There is a future trend toward
an increase in the incidence of secondary glomerular dis-
eases, particularly diabetic nephropathy.
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